Correlation Between Mitsubishi UFJ and Cyclacel Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mitsubishi UFJ and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mitsubishi UFJ and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mitsubishi UFJ Financial and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Mitsubishi UFJ and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mitsubishi UFJ with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mitsubishi UFJ and Cyclacel Pharmaceuticals.

Diversification Opportunities for Mitsubishi UFJ and Cyclacel Pharmaceuticals

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mitsubishi and Cyclacel is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Mitsubishi UFJ Financial and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Mitsubishi UFJ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mitsubishi UFJ Financial are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Mitsubishi UFJ i.e., Mitsubishi UFJ and Cyclacel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Mitsubishi UFJ and Cyclacel Pharmaceuticals

Assuming the 90 days horizon Mitsubishi UFJ Financial is expected to generate 0.36 times more return on investment than Cyclacel Pharmaceuticals. However, Mitsubishi UFJ Financial is 2.76 times less risky than Cyclacel Pharmaceuticals. It trades about 0.28 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  1,135  in Mitsubishi UFJ Financial on November 3, 2024 and sell it today you would earn a total of  165.00  from holding Mitsubishi UFJ Financial or generate 14.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Mitsubishi UFJ Financial  vs.  Cyclacel Pharmaceuticals

 Performance 
       Timeline  
Mitsubishi UFJ Financial 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mitsubishi UFJ Financial are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward-looking indicators, Mitsubishi UFJ reported solid returns over the last few months and may actually be approaching a breakup point.
Cyclacel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Mitsubishi UFJ and Cyclacel Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mitsubishi UFJ and Cyclacel Pharmaceuticals

The main advantage of trading using opposite Mitsubishi UFJ and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mitsubishi UFJ position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.
The idea behind Mitsubishi UFJ Financial and Cyclacel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements